7TFP CDH1 reporter9174 bp40080012001600200024002800320036004000440048005200560060006400680072007600800084008800minPluciferaseSV40 promoterPuroRWPRE3' LTR (Delta-U3)SV40 poly(A) signalSV40 oriT7 promoterM13 fwdf1 oriAmpR promoterAmpRoriL4440CAP binding sitelac promoterlac operatorM13 revT3 promoterRSV promoter5' LTR (truncated)HIV-1 PsiRREgp41 peptideProtein TatcPPT/CTS

基本信息

载体名称
7TFP CDH1 reporter
载体抗性
Ampicillin
载体长度
9174 bp
载体类型
Mammalian Expression, Lentiviral, Luciferase
复制子
ori
筛选标记
Puromycin
拷贝数
High Copy
启动子
RSV
克隆方法
Restriction Enzyme
3'引物
LucNRev

质粒操作方法

质粒复溶方法

  1. 发货形式:质粒干粉,常温运输,收到后请于 -20 ℃ 保存,先转化提质粒再使用。
  2. 收到干粉后先 5000 rpm 离心 1 min,加入 20 μl ddH₂O 溶解。质粒复测浓度与标称值可能有差距,这通常来自干粉在管中的位置、复溶效率、测量偏差与管壁吸附,建议先转化提质粒后再使用。
  3. 取 1 支 100 μl 感受态细胞冰上解冻 10 min,加入 2 μl 质粒,冰浴 30 min,42 ℃ 热激 60 s(不要摇动),再冰浴 2 min。
  4. 加入 900 μl 无抗生素 LB 液体培养基,180 rpm、37 ℃ 振荡培养 45 min(30 ℃ 培养 1–1.5 h)。
  5. 6000 rpm 离心 5 min,保留约 100 μl 上清重悬菌体,涂布到对应抗性的 LB 平板。
  6. 平板倒置 37 ℃ 培养 14 h(30 ℃ 则 20 h)。菌落过多可稀释质粒后再转化;无菌落可增加至 10 μl 质粒。建议先转克隆感受态、重提质粒后再导入表达感受态。
  7. 挑取单菌落接种 LB 液体培养基,加入对应抗生素,220 rpm 振荡培养 14 h,按试剂盒说明提取质粒。

通用质粒转化方法

  1. 取100 μL感受态细胞置于冰上解冻10 min,加入2 μL质粒,冰浴30 min;随后42 ℃热激60 s,期间不要晃动,再冰浴2 min。
  2. 加入900 μL无抗LB液体培养基,37 ℃、180 rpm振荡培养45 min(30 ℃条件下则培养1–1.5 h)。
  3. 6000 rpm离心5 min,弃上清,仅保留100 μL上清重悬菌体沉淀,涂布于对应质粒抗性的LB平板上。
  4. 平板倒置培养,37 ℃培养14 h,或30 ℃培养20 h。
  5. 挑取单菌落至LB液体培养基中,加入对应抗生素,220 rpm振荡培养14 h;根据实验需求及质粒提取试剂盒说明书提取质粒。

7TFP CDH1 reporter 质粒 (编号: V006706) 注释

LOCUS       V006706                 9174 bp    DNA     circular SYN 13-MAY-2021
DEFINITION  Exported.
ACCESSION   V006706
VERSION     V006706
KEYWORDS    7TFP CDH1 reporter
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
            .
REFERENCE   1  (bases 1 to 9174)
  AUTHORS   Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C,
            Reinhardt F, Tam WL, Weinberg RA
  TITLE     Activation of PKA leads to mesenchymal-to-epithelial transition and
            loss of tumor-initiating ability.
  JOURNAL   Science. 2016 Mar 4;351(6277):aad3680. doi: 10.1126/science.aad3680.
   PUBMED   26941323
REFERENCE   2  (bases 1 to 9174)
  TITLE     Direct Submission
REFERENCE   3  (bases 1 to 9174)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "Science.";
            date: "2016-03-4"; pages: "
            10.1126/science.aad3680"
            SGRef: number: 2; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..9174
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     promoter        325..356
                     /label="minP"
                     /note="minimal TATA-box promoter with low basal activity"
     CDS             418..2067
                     /label="luciferase"
                     /note="firefly luciferase"
     promoter        2094..2423
                     /label="SV40 promoter"
                     /note="SV40 enhancer and early promoter"
     CDS             2433..3029
                     /label="PuroR"
                     /note="puromycin N-acetyltransferase"
     misc_feature    3099..3687
                     /label="WPRE"
                     /note="woodchuck hepatitis virus posttranscriptional
                     regulatory element"
     LTR             3774..4007
                     /label="3' LTR (Delta-U3)"
                     /note="self-inactivating 3' long terminal repeat (LTR) from
                     HIV-1"
     polyA_signal    4079..4213
                     /label="SV40 poly(A) signal"
                     /note="SV40 polyadenylation signal"
     rep_origin      4240..4375
                     /label="SV40 ori"
                     /note="SV40 origin of replication"
     promoter        complement(4396..4414)
                     /label="T7 promoter"
                     /note="promoter for bacteriophage T7 RNA polymerase"
     primer_bind     complement(4424..4440)
                     /label="M13 fwd"
                     /note="common sequencing primer, one of multiple similar
                     variants"
     rep_origin      4582..5037
                     /label="f1 ori"
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"
     promoter        5063..5167
                     /label="AmpR promoter"
     CDS             5168..6025
                     /label="AmpR"
                     /note="beta-lactamase"
     rep_origin      6199..6787
                     /label="ori"
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                     replication"
     primer_bind     6941..6958
                     /label="L4440"
                     /note="L4440 vector, forward primer"
     protein_bind    7075..7096
                     /label="CAP binding site"
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     promoter        7111..7141
                     /label="lac promoter"
                     /note="promoter for the E. coli lac operon"
     protein_bind    7149..7165
                     /label="lac operator"
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be
                     relieved by adding lactose or
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     primer_bind     7173..7189
                     /label="M13 rev"
                     /note="common sequencing primer, one of multiple similar
                     variants"
     promoter        7210..7228
                     /label="T3 promoter"
                     /note="promoter for bacteriophage T3 RNA polymerase"
     promoter        7256..7482
                     /label="RSV promoter"
                     /note="Rous sarcoma virus enhancer/promoter"
     LTR             7483..7663
                     /label="5' LTR (truncated)"
                     /note="truncated 5' long terminal repeat (LTR) from HIV-1"
     misc_feature    7710..7835
                     /label="HIV-1 Psi"
                     /note="packaging signal of human immunodeficiency virus
                     type 1"
     misc_feature    8328..8561
                     /label="RRE"
                     /note="The Rev response element (RRE) of HIV-1 allows for
                     Rev-dependent mRNA export from the nucleus to the
                     cytoplasm."
     CDS             8746..8790
                     /label="gp41 peptide"
                     /note="antigenic peptide corresponding to amino acids 655
                     to 669 of the HIV envelope protein gp41 (Lutje Hulsik et
                     al., 2013)"
     CDS             8939..8980
                     /note="Protein Tat from Human immunodeficiency virus type 1
                     group M subtype B (isolate WMJ22). Accession#: P12509"
                     /label="Protein Tat"
     misc_feature    9057..9174
                     /label="cPPT/CTS"
                     /note="central polypurine tract and central termination
                     sequence of HIV-1"